Sandoz launches a generic version of Vantin

PRINCETON, N.J. Generic drug maker Sandoz has launched a version of an oral antibiotic.

The company, a division of Swiss drug maker Novartis, announced the launch of cefpodoxime proxetil oral suspension in the 50 mg per 5 mL and 100 mg per 5 mL strengths, used to treat such mild to moderate infections caused by Gram positive and Gram negative bacteria as ear infections, sore throats and sinusitis.

The drug is a generic version of Pfizer’s Vantin. Branded and generic formulations of cefpodoxime proxetil oral suspension were about $4 million in the 12 months ended in April, according to IMS Health data.